COVID-19 Vaccine Availability
COVID-19 vaccines are available to all U.S. citizens and residents. There are three approved vaccines; Johnson & Johnson/Janssen, Pfizer-BioNTech-Comirnanty, and Moderna. All three vaccines are safe and effective against COVID-19 and its variants.
- The Food and Drug Administration (FDA) has fully authorized the Pfizer COMIRNATY® vaccine for individuals age 16 and older.
- The Pfizer vaccine is offered through an FDA Emergency Use Authorization (EUA) for children ages 12 -15
- The Johnson & Johnson and Moderna vaccines are offered through an FDA EUA for individuals age 18 and older.
DOD COVID-19 Vaccine Mandate
The DOD now requires COVID-19 vaccines for all members of the Armed Forces under DoD authority on active duty or in the Reserve, including and National Guard, who are not fully vaccinated against COVI-19.
- If you’re a service member and you’ve received a COVID-19 vaccine from a non-DOD provider, make sure to update your medical records.
- If you haven’t received your COVID vaccine yet, schedule your vaccine as soon as you can.
- Find a DOD COVID Vaccine Location near you
The DOD already requires all ADSMs to get other types of vaccines before they join the military. There are very narrow religious and medical exemptions available on a case-by-case basis. If you have questions, contact your unit commander.
If you are pregnant or lactating, please review the updated guidance provided.
Recommended Third Shot
If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.
Find out of you should get a third shot.
Local COVID-19 Vaccine Guidance
We are working to notify immunocompromised patients who qualify for the Pfizer BioNTech booster.
Moderately and Severely Immunocompromised Patients* Who Qualify
* ACIP General Best Practice Guidelines for Immunization; CDC Yellow Book; 2013 IDSA Clinical Practice Guidelines for Vaccination of the Immunocompromised Host
- Active treatment for solid tumor and hematologic malignancies
- Receipt of solid-organ transplant and taking immunosuppressive therapy
- Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
- Moderate or severe primary immunodeficiency (e.g., DiGeorge, Wiskott-Aldrich syndromes)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, TNF blockers, and other biologic agents that are immunosuppressive or immunomodulatory